Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Virus Diseases × Papillomavirus Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 5 Uterine Cervical Neoplasms 3 Condylomata Acuminata 2 Vulvar Neoplasms 1 Virus Diseases 1 Vaginal Neoplasms 1 Anus Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 halofantrine 1 Papillomavirus Vaccines 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

GlaxoSmithKline

Phase 1 Completed

961 enrolled 43 charts

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡